Cargando…
Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A
With therapeutic trials on the horizon for Charcot-Marie-Tooth type 1A (CMT1A), reliable, valid, and responsive clinical outcome assessments and biomarkers are essential. Accelerate Clinical Trials in CMT (ACT-CMT) is an international study designed to address important gaps in CMT1A clinical trial...
Autores principales: | Eichinger, Katy, Sowden, Janet E., Burns, Joshua, McDermott, Michael P., Krischer, Jeffrey, Thornton, John, Pareyson, Davide, Scherer, Steven S., Shy, Michael E., Reilly, Mary M., Herrmann, David N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271780/ https://www.ncbi.nlm.nih.gov/pubmed/35832173 http://dx.doi.org/10.3389/fneur.2022.930435 |
Ejemplares similares
-
Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
por: Pareyson, Davide, et al.
Publicado: (2011) -
Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT
por: Prada, Valeria, et al.
Publicado: (2021) -
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry
por: Bellofatto, Marta, et al.
Publicado: (2022) -
Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies
por: Østern, Rune, et al.
Publicado: (2013) -
Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success
por: Timmerman, Vincent, et al.
Publicado: (2014)